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Abstract  
Introduction: COVID-19 pandemic led to various consequences in medical care that had been long provided 
for the patients referred to the hospitals.  
Objective: We conducted this study to derive and validate a new scoring system that can accurately 
differentiate COVID-19 patients who may have a worse outcome from others at the prehospital stage.  
Methods: This study was performed on probable/confirmed COVID-19 patients, who were transferred to the 
hospitals by Tehran emergency medical services (EMS). Occurrence of one of the items including: in-hospital 
death, intensive care unit (ICU) admission, or hospitalization for more than 20 days was considered to indicate 
a “severe disease”. Univariate and multivariate logistic regression were used for assessment of the relationship 
between all independent variables and the outcome. In the validity assessment step, area under the receiver 
operating characteristic (ROC) curve was calculated for a data set independent from the data based on which 
the model was designed. The sensitivity and specificity were also presented based on the best suggested cut-
off point.  
Results: In this study, the data of 557 cases were analyzed in the derivation step and 356 cases were assessed 
in the validation step. The univariate logistic regression showed that age, weakness and fatigue, disease 
history, systolic blood pressure, SpO2, respiratory rate, and Glasgow coma scale (GCS) were statistically 
significant in severe disease group. The area under the ROC curve (AUC-ROC) of the tool was 0.808 (95% CI: 
0.779, 0.834). The best cut-off point for screening was the score of ≥4, in which the sensitivity and specificity 
of the tool for the best cut-off point were 71.87% and 78.06%, respectively. In the validation step, the AUC-
ROC of the tool was 0.723. 
Conclusions: Seven criteria of severe COVID-19 (SCSC) tool could properly differentiate probable/confirmed 
COVID-19 patients with severe outcomes in the pre-hospital stage. 
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INTRODUCTION
COVID-19 pandemic led to various consequences in 
medical care that had been long provided for the 
patients referred to the hospitals (1, 2). It is well-
known that the disease can present with a wide 
range of manifestations from asymptomatic 
infection to severely morbid disease. Although 
most patients are affected with a minor illness, but 
still some are affected with a severe form that 
necessitates being hospitalized or even admitted to 
intensive care unit (ICU) (3). The pandemic 
overwhelmed and increased the workload of 
medical staff both at the prehospital and hospital 
stages, as a considerable number of people seek 
care in dealing with COVID-19. Apparently, most of 
the patients who call the Emergency Medical 
Services (EMS) in this regard do not need any 
specific care but still, some must be transferred to 
hospitals (4, 5). Therefore, it seems that a scoring 
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system, which can predict the outcome, would be of 
great help for the triage of patients in this step. It is 
expected that such a scoring system can accurately 
differentiate those who may develop the severe 
form of the disease from the others (6, 7). There are 
several prehospital triage scoring systems that 
have been previously used in dealing with septic 
patients such as the qSOFA, SOFA, NEWS, and 
PRESEP (8-10); but we found that none of them 
have proper efficacy to predict death, ICU 
admission, and disease severity of COVID-19 
patients. Therefore, we conducted this study to 
derive and validate a new scoring system that can 
accurately differentiate COVID-19 patients who 
may have a worse outcome from others at the 
prehospital stage.  
Methods 
Study design and setting  
This study was performed on patients older than 
16 years old who were transferred to the hospitals 
by Tehran EMS from February 20 until March 19, 
2020, and were diagnosed as a probable or 
confirmed case of COVID-19 (11). Death at the 
scene, missing data in pre-hospital/hospital 
records, and unwillingness of the patient or his/her 
relatives to participate in the study were 
considered as exclusion criteria. The proposal of 
the study was approved by the ethics committee of 
Iran University of Medical Sciences (code: 
IR.IUMS.REC.1399.225). To adhere to the 
principles of confidentiality, all information was 
used anonymously throughout the study. 
Study population 
In this study, the relationship between 15 
independent variables and the outcome was 
evaluated. Assuming a 20% prevalence of severe 
outcome (meeting one of the criteria of >20 days of 
hospitalization, ICU admission, or death) in 
probable COVID-19 cases, and considering 10 
patients per independent variable, we needed 750 
patients to examine the relationship between the 
independent variables and dual state outcome 
using logistic regression. Also, assuming 15% 
sample loss in follow-up, the minimum required 
sample size in this study was 865. Sampling was 
based on the transferred COVID-19 missions from 
February 20, 2020 until March 19, 2020), and was 
performed using simple random sampling. All 
included patients were followed up within two 
months after the call (mission) for the intended 
outcomes of the study. 
Data gathering 
The information of the patients at the pre-hospital 
stage was extracted from the data registry of 
Tehran EMS center using a pre-prepared checklist. 
The required data included demographic 
information (age, gender), accompanying 
symptoms (fever, shortness of breath, weakness, 
and fatigue), past medical history (diabetes 
mellitus, cardiovascular disease (CVD), respiratory 
disease), and vital signs (systolic and diastolic 
blood pressure, SpO2, respiratory rate, pulse rate, 
tympanic temperature, and Glasgow coma scale 
(GCS)). 
Outcome assessment 
We aimed to derive a scoring system to 
differentiate patients with severe form of COVID-
19 disease from the others. Due to the limited 
capacity of the ICU beds, it was impossible to admit 
all patients (despite their need) to the ICU; 
Therefore, beside in-hospital death and ICU 
admission, we considered hospitalization for more 
than 20 days as an indicator of severe disease. The 
outcome of the patients was assessed through a 
telephone follow-up.  
Data validity 
To assess the validity of the proposed tool, the data 
in the registry database of the Ministry of Health 
was used to screen the patients. The minimum 
sample size required for testing the validity of the 
tool was calculated to be 360, based on assuming 
75% sensitivity for the proposed screening tool, 
20% prevalence of severe outcome in probable 
COVID-19 patients, 10% probability of error in 
estimation of sensitivity, and a type 1 error of 5%. 
For this purpose, from all probable COVID-19 cases 
recorded during the period from February 20, 
2020, to July 21, 2020, 360 cases were selected, 
using random sampling, and the patients' outcome 
was investigated through integrating the data with 
the hospital data. In evaluating the validity of the 
proposed tool for screening probable COVID-19 
patients at the scene, patients with severe disease 
were those who had one of the criteria of 
hospitalization >20 days, ICU admission, or death. 
Statistical analysis 
After providing descriptive data, the variables were 
compared in the two groups of patients with severe 
and non-severe disease. For quantitative variables, 
the mean difference between the two groups was 
analyzed using Independent T-test, and for 
qualitative variables, the frequency distribution 
difference between the two groups was evaluated 
using χ2 test. Using Univariate logistic regression 
test, the relationship between all variables and the 
dual state outcome of the study was investigated, 
and finally, the Multivariate model was applied 
using the Backward Stepwise (Likelihood Ratio) 
method. To calculate the cut-off points of the 
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remaining quantitative variables in the final model 
of predicting patients' prognosis, J-Youden index 
and the Clinician's opinion were used. In addition, 
different cut-off points were assessed and the best 
cut-off points and the scores of the variables were 
calculated for screening and the best scenario was 
selected based on the area under the receiver 
operating characteristic (ROC) curve (AUC-ROC) 
index. The best cut-off point for the final screening 
score of patients at the scene was selected using the 
J-Youden statistics. In examining the validity, the 
area under the ROC curve was calculated for a data 
set independent from the data based on which the 
model was designed. The sensitivity and specificity 
were also presented with 95% confidence interval 
based on the best suggested cut-off point. All 




In this study, the data of 821 individuals with 
probable/confirmed COVID-19 diagnosis were 
analyzed. In total, 376 (45.8%) were male and the 
rest were female. The mean age of studied patients 
was 55.8 years (standard deviation (SD) = 17.8), 
and patients with severe disease were significantly 
older than those with non-severe disease (70.9 vs 
52.1, P-value<0.001). The prevalence of severe 
illness was 19.5%.  
Of all patients, 104 (12.7%) died, 105 (12.8%) were 
admitted to the ICU, and 24 (2.9%) were 
hospitalized for more than 20 days. Also, of all 
patients, 354 (43.1%) were not hospitalized (did 
not need to be hospitalized) and 130 (15.8%) were 
hospitalized for 1-3 days. The overall mean length 
of hospital stay for the studied patients was 4.4 
days (SD = 6.8). Of all patients, 61.9% in the severe 
group and 49.5% in the non-severe group had 
symptoms of weakness and fatigue, and this 
difference was statistically significant (P-value = 
0.005). History of diabetes, cardiovascular 
diseases, or respiratory diseases was significantly 
more prevalent among patients in severe group (P-
value <0.05). The mean percentage of SpO2 for 
patients with severe disease was 87.2%, which was 
significantly lower than that of patients with non-
severe disease (P-value <0.001). Mean Respiratory 
Rate was also significantly higher in patients with 
severe disease (17.7 vs 17.2, p = 0.032). Moreover, 
7.5% and 1.5% of patients in severe and non-
severe groups had GCS <15, respectively (P <0.001) 
(Table 1).  
The univariate logistic regression showed that age, 
weakness and fatigue, disease history, systolic 
blood pressure, SpO2, respiratory rate, and GCS 
were statistically significant different between the 
2 groups. In the multivariate logistic regression 
model, old age (OR=1.06 per year), weakness and 
fatigue (OR=4.8), lower SpO2 (OR=19.6), and GCS 
lower than 15 (OR=2.1) had a significant role in 
predicting the severity of the disease in probable 
COVID-19 patients. Also, a positive history of 
diabetes (OR=1.03), CVD (OR=1.6) and higher 
respiratory rate (OR=1.1) were important and 
were kept in the model (Table 2). The Nagelkerke 
R Square for the multivariate logistic model was 
0.338.  
Table 1: Demographic and clinical characteristics of the studied patients in the severe and non-severe disease groups   
 Non-severe (n=661); 
n (%) or mean (SD) 
Severe (n=160); 
n (%) or mean (SD) 
P-value 
Age, year 52.1 (16.6) 70.9 (14.5) <0.001 
Sex, Male 290 (66.4) 86 (72.3) 0.222 
Accompanying symptoms 
     Fever 
     Shortness of breath 














     Diabetic 
     Cardiovascular disease 













Systolic blood pressure 119.1 (14.5) 123.3 (16.7) 0.004 
Diastolic blood pressure 75.6 (8.2) 77.0 (9.3) 0.080 
SpO2 91.5 (5.5) 87.2 (8.1) <0.001 
Respiratory rate 17.2 (1.9) 17.7 (2.8) 0.032 
Pulse rate 90.7 (14.2) 91.3 (17.1) 0.661 
Temperature 38.1 (0.84) 38.1 (0.83) 0.642 
GCS<15 10 (1.5) 12 (7.5) <0.001 
Definitive case of COVID-19 20 (12.7) 132 (22.3) 0.007 
SD: Standard deviation; GCS: Glasgow coma scale 
FRONTIERS IN EMERGENCY MEDICINE. 2021;5(3):e29 Saberian et al. 
   
 
4 Copyright © 2021 Tehran University of Medical Sciences 
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). 
Noncommercial uses of the work are permitted, provided the original work is properly cited. 
Table 3 shows the suggested scoring system. The 
best screening cut-off points for age and SpO2 were 
considered 60 and 80 years old, and 93% and 88%, 
respectively; and 20 breaths/min for respiratory 
rate. The point given to each of the items of age≥80, 
SpO2≤88%, and a positive history of CVD was 3, 
which is higher than other variables.  
The Hosmer and Lemeshow goodness-of-fit test 
gave a P-value of 0.623, thereby showing that the 
model had a good fitting. The AUC-ROC of the 
screening tool was 0.808 (95% CI: 0.779, 0.834) 
(Figure 1). The best cut-off point for screening was 
a score≥4. The sensitivity and specificity of the tool 
in the best cut-off point were 71.87% (95% CI: 
64.2%, 78.7%) and 78.06% (95% CI: 74.7%, 
81.2%), respectively (Table 4). 
Validity assessment  
In the Validity Analysis stage of the proposed 
scoring tool, after excluding patients with missing 
data, the data of 356 individuals were analyzed, 
Table 2: Univariate and multivariate logistic regression analyses  
 Univariate Multivariate 
Wald OR 95% CI P-Value Wald OR 95% CI P-Value 
Age, year 115.5 1.08 1.07, 1.09  <0.001 74.3 1.06 1.05, 1.08 <0.001 
Sex, Male 1.5 1.3 0.84, 2.1 0.223     
Accompanying symptoms 
     Fever 
     Shortness of breath 


































     Diabetic 
     Cardiovascular disease                             






























Systolic blood pressure 9.8 1.02 1.0, 1.03 0.002     
Diastolic blood pressure 3.6 1.02 0.99, 1.04 0.059     
SpO2 44.7 0.91 0.89, 0.94 <0.001 19.6 0.94 0.91, 0.96 <0.001 
Respiratory rate 7.2 1.1 1.0, 1.2 0.007 2.8 1.1 0.99, 1.2 0.096 
Pulse rate 0.24 1.0 0.99, 1.0 0.623     
Temperature 0.22 1.1 0.84, 1.3 0.642     
GCS<15 14.4 5.3 2.2, 12.4 <0.001 2.1 2.1 0.77, 5.7 0.148 
 CI: Confidence interval; OR: Odds ratio; GCS: Glasgow coma scale 
 
Table 3: Variable, cut-off and score of suggested seven criteria of severe COVID-19 (SCSC) screening tool and result of its validity 
assessment 
Variable Score Result of validity data 
Age, year ≥80 3 66 (18.5) 
60-79 1 116 (32.6) 
<60 0 174 (48.9) 
SpO2  ≤88% 3 102 (29.1) 
89-93% 1 125 (35.6) 
≥94% 0 124 (35.3) 
Respiratory rate, breaths per minute >20 1 22 (6.4) 
12-20 0 321 (93.6) 
Diabetic Positive 1 60 (16.9) 
Negative 0 296 (83.1) 
Cardiovascular disease 
 
Positive 3 63 (17.7) 
Negative 0 293 (82.3) 
Glasgow coma scale <15 1 40 (11.2) 
=15 0 316 (88.8) 
Weakness and fatigue Positive 1 207 (58.1) 
Negative 0 149 (41.9) 
 
Table 4: Statistical values for each cut-off point of seven criteria of severe COVID-19 (SCSC) scoring model 
Cut-off Sensitivity (95% CI) Specificity (95% CI) PLR (95% CI) NLR (95% CI) 
>1 91.25 (85.8, 95.1) 40.09 (36.3, 43.9) 1.52 (1.4, 1.6) 0.22 (0.1, 0.4) 
>2 81.87 (75.0, 87.5) 64.90 (61.1, 68.5) 2.33 (2.1, 2.6) 0.28 (0.2, 0.4) 
>3 71.87 (64.2, 78.7) 78.06 (74.7, 81.2) 3.28 (2.8, 3.9) 0.36 (0.3, 0.5) 
>4 54.37 (46.3, 62.3) 89.26 (86.6, 91.5) 5.06 (3.9, 6.6) 0.51 (0.4, 0.6) 
>5 29.37 (22.4, 37.1) 95.92 (94.1, 97.3) 7.19 (4.6, 11.2) 0.74 (0.7, 0.8) 
NLR: Negative likelihood ratio; PLR: Positive likelihood ratio; CI: Confidence interval 
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214 (60.1%) of which were male. The mean age of 
patients was 59.4 years (SD = 19.5). 29.1% of 
patients had SpO2≤88% and 6.4% had respiratory 
rate (RR) >20. 16.9% and 17.7% of the total 
patients reported a history of diabetes and heart 
disease, respectively (Table 3). The outcome was 
severe in 81 of the studied patients (22.8%); out of 
which, 73 patients died in the hospital, and 8 were 
discharged after more than 20 days of 
hospitalization. The area under the ROC curve of 
the proposed instrument was 0.723. Also, at the 
proposed cut-off point, its sensitivity and 
specificity in screening of severe patients were 
70.4% (95% CI: 59.2, 80.0) and 61.8% (95% CI: 
55.8, 67.6), respectively.  
DISCUSSION 
In this study, we suggested a new model, seven 
criteria of severe COVID-19 (SCSC), which can 
screen COVID-19 patients who may later face 
severe consequences in the prehospital stage; so 
that they can be prioritized over others who need 
less care and be transferred to the hospital more 
rapidly. This model was derived and also validated 
based on usually obtained information, which is 
easily available to EMTs when they tend to a 
patient. This simple tool is a clinical prediction rule 
that can help in triage of patients in the pre-
hospital setting without the need for any 
paraclinical test. The need for such a tool is 
undeniable, because the future of COVID-19 
pandemic is uncertain and no one can yet imagine 
its end; and it is commonly known that the disease 
has multiplied the workload of the emergency 
services, at both prehospital and hospital stages. In 
different countries, and after the initial peak of the 
disease, a relative decline in statistics was 
observed, but unfortunately, after the weakening of 
quarantine conditions, it increased again, and in 
fact, its future is not clear and predictable at all. 
Pros and cons 
What is obvious is that although this tool is not 
100% accurate, it could still properly differentiate 
those with severe consequences from the others. In 
its best cut off point, which was statistically 
calculated as score ≥4, this tool has 71.87% 
sensitivity and 78.06% specificity. But if 
policymakers decide to use maximum sensitivity or 
specificity, other cut-offs must be considered 
proportionally. It is necessary to design another 
study with the same tool and objectives to 
accurately examine the validity of the tool and its 
power of prediction. 
Limitations 
The data used in the derivation phase of this study 
was collected in the first month of the epidemic, at 
which time, according to the instructions, almost all 
probable COVID-19 cases were transported to 
hospitals by the pre-hospital emergency. In fact, at 
that time, there was no tool for screening severe 
patients from non-severe ones. Therefore, the 
studied cases included severe to mild cases of 
COVID-19, and that is why we had a percentage of 
non-hospitalized cases in this study population. 
Also, at this stage, the cases were followed up by 
telephone two months after their call to the EMS. 
However, in the data used in the validity 
assessment phase, the required data was extracted 
from different populations and the outcome was 
based on hospital records and did not include 
possible deaths after discharge. Therefore, the 
different methods of investigating the outcome in 
these two study populations may be one of the 
reasons for the decline in accuracy indicators when 
examining the validity of the proposed tool. 
CONCLUSIONS 
In this study, we introduced a new prognostic 
scoring tool, seven criteria of severe COVID-19 
(SCSC), which could properly differentiate 
probable/confirmed COVID-19 patients with 
severe consequences from others in the pre-
hospital stage. 
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